Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and therapeutic effect of ex-vivo
expanded umbilical cord blood regulatory T cells adjunct with Liraglutide on autoimmune
diabetes.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Second Xiangya Hospital of Central South University